Allergy Therapeutics

“Since appointment, Panmure’s commitment and willingness to understand the Company’s business and strategy has contributed to Allergy achieving its corporate goals and increasing shareholder value. Panmure’s execution of our two transactions has been first-class, connecting us with new institutional investors while effectively managing and supporting the existing shareholder base. The Healthcare team has demonstrated its extensive knowledge of the sector throughout.”